Nasal spray to prevent respiratory infections in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This trial tests a nasal spray, INNA-051, that may help your nose and airways fight off viruses that cause respiratory infections like colds and flu. It is for healthy adults aged 18-45 who are around many people and may be exposed to germs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 45 years old and in overall good health, without chronic conditions like diabetes, asthma, or other respiratory diseases.
- You have regular contact with many people (for example, you work in healthcare, childcare, or a crowded environment, or you live in shared housing or a dormitory).
- You do not currently have cold or flu symptoms (like a runny nose, cough, or fever).
- You have not received an RSV vaccine in the last 90 days.
- You agree to use reliable birth control if you are of childbearing potential.
- You have no history of HIV, hepatitis B, or untreated hepatitis C.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a flu vaccine given as a nasal spray instead of a shot. It aims to see how well it protects adults aged 18 to 59 from getting the flu.
This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.
This trial studies how healthy adults respond to the nasal flu vaccine (FluMist). It aims to understand immune responses and may help improve future flu vaccines.
This trial tests a new nasal spray (called LMN-1001) in healthy adults to see if it is safe and how the body handles it. It is an early-phase study, so the main goal is not to treat a disease but to check for safety and side effects.
This study tests treatments for the common cold, sinus pain, or sore throat caused by a virus. It compares different options to see which works best for reducing symptoms like runny nose, congestion, and cough.
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
Hear when a new Viral Respiratory Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.